Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
H.AbramsonS
acarbose can be added to these measures in patients with hypoglycemia In patients who have not responded to initial therapy, (slow-release) somatostatin analogs are the treatment of choice In patients with treatment-refractory dumping syndrome, surgical reinterventions or continuous enteral feeding can be considered, but the outcomes of such approaches are variable This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access 189,00 per year only 15,75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Xerostomia (Fig
A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis
The table below reflects approximate costs as of 2025
Among the factors influencing its duration are injection site, treatment frequency, tissue injury severity, and individual metabolism
US$ 29.45
US$ 21.04
US$ 28.48
US$ 23.97
